大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/07 | 7,420 | 7,488 | 7,341 | 7,426 | -50 | -0.7% | 1,123,100 |
2025/03/06 | 7,418 | 7,560 | 7,414 | 7,476 | +58 | +0.8% | 1,161,100 |
2025/03/05 | 7,465 | 7,479 | 7,296 | 7,418 | +12 | +0.2% | 885,300 |
2025/03/04 | 7,299 | 7,483 | 7,293 | 7,406 | +107 | +1.5% | 1,350,500 |
2025/03/03 | 7,449 | 7,450 | 7,271 | 7,299 | -26 | -0.4% | 977,400 |
2025/02/28 | 7,220 | 7,342 | 7,206 | 7,325 | -22 | -0.3% | 1,745,600 |
2025/02/27 | 7,379 | 7,416 | 7,290 | 7,347 | -31 | -0.4% | 1,085,800 |
2025/02/26 | 7,349 | 7,397 | 7,233 | 7,378 | +29 | +0.4% | 1,058,800 |
2025/02/25 | 7,222 | 7,400 | 7,200 | 7,349 | +155 | +2.2% | 1,565,800 |
2025/02/21 | 7,207 | 7,298 | 7,163 | 7,194 | +62 | +0.9% | 1,088,800 |
2025/02/20 | 7,188 | 7,209 | 7,054 | 7,132 | -115 | -1.6% | 1,750,700 |
2025/02/19 | 7,421 | 7,457 | 7,247 | 7,247 | -236 | -3.2% | 1,398,200 |
2025/02/18 | 7,550 | 7,676 | 7,483 | 7,483 | -117 | -1.5% | 1,144,100 |
2025/02/17 | 7,370 | 7,718 | 7,244 | 7,600 | +275 | +3.8% | 2,145,900 |
2025/02/14 | 8,050 | 8,099 | 7,325 | 7,325 | -796 | -9.8% | 2,400,400 |
2025/02/13 | 8,000 | 8,190 | 7,991 | 8,121 | +215 | +2.7% | 982,300 |
2025/02/12 | 8,010 | 8,075 | 7,897 | 7,906 | -127 | -1.6% | 1,396,900 |
2025/02/10 | 7,927 | 8,044 | 7,919 | 8,033 | +107 | +1.3% | 593,000 |
2025/02/07 | 7,948 | 8,023 | 7,909 | 7,926 | -82 | -1% | 519,600 |
2025/02/06 | 8,061 | 8,117 | 7,995 | 8,008 | +34 | +0.4% | 657,900 |
2025/02/05 | 7,987 | 8,058 | 7,933 | 7,974 | -99 | -1.2% | 677,600 |
2025/02/04 | 8,157 | 8,160 | 7,995 | 8,073 | +66 | +0.8% | 733,500 |
2025/02/03 | 7,986 | 8,051 | 7,854 | 8,007 | -129 | -1.6% | 1,022,200 |
2025/01/31 | 8,110 | 8,179 | 8,079 | 8,136 | +39 | +0.5% | 831,000 |
2025/01/30 | 8,145 | 8,195 | 8,061 | 8,097 | -98 | -1.2% | 1,435,000 |
2025/01/29 | 8,115 | 8,199 | 8,067 | 8,195 | +81 | +1% | 1,042,000 |
2025/01/28 | 8,070 | 8,239 | 8,070 | 8,114 | +80 | +1% | 1,038,700 |
2025/01/27 | 8,051 | 8,121 | 8,014 | 8,034 | +28 | +0.3% | 798,100 |
2025/01/24 | 8,016 | 8,030 | 7,949 | 8,006 | +56 | +0.7% | 762,500 |
2025/01/23 | 7,970 | 7,992 | 7,912 | 7,950 | -52 | -0.6% | 834,800 |
2025/01/22 | 8,051 | 8,066 | 7,944 | 8,002 | -14 | -0.2% | 884,000 |
2025/01/21 | 8,025 | 8,087 | 7,972 | 8,016 | +9 | +0.1% | 628,400 |
2025/01/20 | 7,949 | 8,036 | 7,926 | 8,007 | +45 | +0.6% | 777,300 |
2025/01/17 | 7,970 | 8,000 | 7,925 | 7,962 | -42 | -0.5% | 980,000 |
2025/01/16 | 8,081 | 8,118 | 8,004 | 8,004 | -59 | -0.7% | 800,300 |
2025/01/15 | 8,121 | 8,216 | 8,013 | 8,063 | +12 | +0.1% | 939,200 |
2025/01/14 | 7,940 | 8,074 | 7,817 | 8,051 | -12 | -0.1% | 1,685,500 |
2025/01/10 | 8,383 | 8,431 | 8,035 | 8,063 | -351 | -4.2% | 1,759,200 |
2025/01/09 | 8,362 | 8,453 | 8,348 | 8,414 | +5 | +0.1% | 869,800 |
2025/01/08 | 8,450 | 8,519 | 8,320 | 8,409 | -102 | -1.2% | 1,160,600 |
2025/01/07 | 8,450 | 8,631 | 8,428 | 8,511 | +101 | +1.2% | 849,800 |
2025/01/06 | 8,601 | 8,625 | 8,363 | 8,410 | -190 | -2.2% | 1,162,200 |
2024/12/30 | 8,657 | 8,673 | 8,577 | 8,600 | -57 | -0.7% | 817,400 |
2024/12/27 | 8,600 | 8,716 | 8,574 | 8,657 | +21 | +0.2% | 1,153,900 |
2024/12/26 | 8,560 | 8,663 | 8,555 | 8,636 | +51 | +0.6% | 1,145,900 |
2024/12/25 | 8,593 | 8,611 | 8,503 | 8,585 | -9 | -0.1% | 654,100 |
2024/12/24 | 8,587 | 8,627 | 8,571 | 8,594 | -6 | -0.1% | 449,700 |
2024/12/23 | 8,475 | 8,640 | 8,464 | 8,600 | +117 | +1.4% | 785,500 |
2024/12/20 | 8,520 | 8,535 | 8,376 | 8,483 | -51 | -0.6% | 2,780,100 |
2024/12/19 | 8,521 | 8,641 | 8,521 | 8,534 | -75 | -0.9% | 680,800 |
101~
150
件表示中 / 3580件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 745,800円 | +2.2% | +28.0% | 1.88% | 11.94倍 | 1.45倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 367,800円 | +6.0% | +4.0% | 2.12% | 22.84倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 421,700円 | -1.1% | +75.3% | 4.74% | 29.21倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 157,600円 | +0.9% | +380.2% | 4.95% | 21.71倍 | 1.87倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,700円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム